Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
A well-known TV medic is receiving widespread support following a devastating disclosure on Instagram. Dr Amir Khan, who regularly provides health guidance across social media platforms and daytime ...
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 IRVINE, California – ...
Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results